How much has Diagonal Therapeutics raised?
$271.3Macross 2 recorded rounds · Apr 2024 – Jan 2026
Most recently, Diagonal Therapeutics raised $125.0M in its Early Stage VC (Series B) (Jan 2026).
Free account
More of Diagonal Therapeutics with a free account
- ·The complete investor list: 17 names
- ·Watch Diagonal Therapeutics: the Monday email on marks, rounds and moves
Diagonal Therapeutics round by round
2 roundsJan 2026Early Stage VC (Series B)$125.0M▮
+ 2 more investors · free account
Apr 2024Early Stage VC (Series A)$128.0M▮
+ 2 more investors · free account
How much has Diagonal Therapeutics raised?
Diagonal Therapeutics has raised $271 million across 2 recorded rounds since 2024. The largest was a $128 million Series A in Apr 2024; the most recent was a $125 million Series B in Jan 2026.
Diagonal Therapeutics investors
17 investors are on record for Diagonal Therapeutics, including Lightspeed Venture Partners, Viking Global Investors, RA Capital Management and Logos Capital. By type, the record holds 5 hedge funds, 3 venture capital firms and 2 asset managers. The Series B in Jan 2026 drew 16 investors.
For fundraisers
Raising for a company like Diagonal Therapeutics?
17 investors have backed Diagonal Therapeutics — start your target list with the firms already writing checks in drug discovery.
Frequently asked about Diagonal Therapeutics
- How much has Diagonal Therapeutics raised?
- Diagonal Therapeutics has raised $271.3M in total across 2 recorded funding rounds.
- When was Diagonal Therapeutics's last funding round?
- Diagonal Therapeutics's most recent recorded round was Early Stage VC (Series B) in Jan 2026, raising $125.0M.